The Role of CMAs in Quality by Design (QbD): Quality cannot be tested into a product. It must be designed into it. In the QbD paradigm, Critical Material Attributes (CMAs) are the variables that determine whether that design holds or collapses when raw materials arrive at your dock.
The Future of the Modern Laboratory Is Here: Introducing Mivado GlobalPerformance’s AI-Driven LIMS – In today’s fast-paced scientific and industrial landscape, laboratories are under more pressure than ever to deliver faster results and maintain airtight compliance.
Tagged : AI, AI-LIMS, APQR, Biopharma, Biopharmaceutical, Compliance, Digital Transformation, Digitalization, GxP, Health Canada, LIMS, Quality 4.0
The Algorithm of Biopharma Compliance in Canada : Navigating Health Canada’s AI Regulatory Shift In the fast-evolving landscape of Canadian life sciences where “innovation” is no longer just about the molecule. It’s about the machine.
Tagged : AI, APQR, Biopharmaceutical, Compliance, Data Integrity, Digital Transformation, GxP, Health Canada, quality, Quality 4.0
The biopharmaceutical industry operates within a complex web of regulatory requirements, demanding meticulous attention to quality and compliance at every stage of a project. From early-stage research to commercial manufacturing, deviations can have significant consequences, impacting patient safety, product efficacy, and the company’s reputation. Optimizing quality and compliance is not merely about ticking boxes; it’s a strategic imperative that drives efficiency, reduces risks, and fosters innovation.
Definition Validation Master Plan is an approved written plan of objectives and actions stating how and when a company will achieve compliance with the GMP requirements regarding validation. It is a document which defines the intentions and the methods that are related with validation of facilities, utilities, system, equipment, instruments, materials, analytical methods, It Systems, cleaning procedures